CIBC World Market
DYN icon

CIBC World Market’s Dyne Therapeutics DYN Stock Holding History

CIBC World Market’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.68M Buy
75,783
+6,568
+9% +$122K ﹤0.01% 894
2026
Q1 		$1.25M Buy
69,215
+449
+0.7% +$7.74K ﹤0.01% 873
2025
Q4 		$1.35M Buy
+68,766
New +$1.3M ﹤0.01% 866

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

CIBC World Market's DYN Position: Q2 2026 in Review

CIBC World Market increased its Dyne Therapeutics (DYN) stake by 9.5% in Q2 2026, buying an estimated $122K and bringing the position to 75,783 shares worth $1.68M. The position accounts for ﹤0.01% of the portfolio, ranked #894.

CIBC World Market first reported a position in DYN in Q4 2025 and has held it in 3 quarters since. 245 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • CIBC World Market held 75,783 shares of Dyne Therapeutics worth $1.68M as of Q2 2026.
  • CIBC World Market bought 6,568 Dyne Therapeutics shares in Q2 2026, an estimated $122K.
  • Dyne Therapeutics made up ﹤0.01% of CIBC World Market's portfolio in Q2 2026, its #894 holding.
  • CIBC World Market first reported a position in Dyne Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 245 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on CIBC World Market's 13F filing for Q2 2026, filed 13 Aug 2026.